dc.creatorZUCCONI, Eder
dc.creatorVALADARES, Marcos Costa
dc.creatorVIEIRA, Natassia M.
dc.creatorBUENO JR., Carlos R.
dc.creatorSECCO, Mariane
dc.creatorJAZEDJE, Tatiana
dc.creatorSILVA, Helga Cristina Almeida da
dc.creatorVAINZOF, Mariz
dc.creatorZATZ, Mayana
dc.date.accessioned2012-10-18T23:13:59Z
dc.date.accessioned2018-07-04T14:46:20Z
dc.date.available2012-10-18T23:13:59Z
dc.date.available2018-07-04T14:46:20Z
dc.date.created2012-10-18T23:13:59Z
dc.date.issued2010
dc.identifierNEUROMUSCULAR DISORDERS, AMSTERDAM, v.20, n.1, p.64-70, JAN, 2010
dc.identifier0960-8966
dc.identifierhttp://producao.usp.br/handle/BDPI/17424
dc.identifier10.1016/j.nmd.2009.10.011
dc.identifierhttp://dx.doi.org/10.1016/j.nmd.2009.10.011
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1614229
dc.description.abstractOf the various genetic homologues to Duchenne Muscular Dystrophy (DMD), the Golden Retriever Muscular Dystrophy (GRMD) dog, which presents a variable but usually severe and progressive muscle weakness, has the closest relevance to DMD in both clinical severity and histopathological change. Among 77 GRMD dogs born in our colony in Brazil, we have identified a very mildly affected dog, Ringo, born July 2003. Among his descendants, at least one male, Suflair, is also showing a mild course. In an attempt to better characterize these two dogs, we studied the pattern of muscle proteins expression in Ringo and Suflair, as compared to severely affected and normal control dogs. Dystrophin was absent in both and utrophin was overexpressed in a pattern similar to the observed in severely affected dogs. Understanding the mechanism that is protecting Ringo and Suflair from the deleterious effect of the dystrophin gene mutation is of utmost interest, In addition it points out that the clinical impact of therapeutic trials should be interpreted with caution. (C) 2009 Elsevier B.V. All rights reserved.
dc.languageeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.publisherAMSTERDAM
dc.relationNeuromuscular Disorders
dc.rightsCopyright PERGAMON-ELSEVIER SCIENCE LTD
dc.rightsrestrictedAccess
dc.subjectGolden Retriever Muscular Dystrophy
dc.subjectDuchenne Muscular Dystrophy
dc.subjectDystrophin
dc.subjectMild phenotype
dc.titleRingo: Discordance between the molecular and clinical manifestation in a Golden Retriever Muscular Dystrophy dog
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución